The DMCB can only hope that this new business-oriented posture may portend some flexibility in health system redesign. Which is why it's important to note that the disease management vendors know a thing or two about simultaneously delivering programs and conducting outcomes studies. They've developed "real world" approaches to study design, understand how to partner in large regional interventions and, what's more, know the good, the bad and the ugly of dealing with Washington DC. Who cares what color the cat is so long as it catches mice?
One not-for-profit managed care organization executive's description of a key attribute they leveraged to get buy-in from their network physicians: